Identification a Novel Molecular Mechanism Underlying the Anti-CD38-Based Treatment Resistance in Multiple Myeloma Patients

被引：2

作者：

Adamia, Sophia ^{[1
,2
,3
]}

Ogiya, Daisuke ^{[4
]}

Hatjiharissi, Evdoxia ^{[5
]}

Chu, Michael P. ^{[6
]}

Chyra, Zuzana ^{[7
,8
,9
]}

Wen, Kenneth ^{[10
]}

Tai, Yu-Tzu ^{[11
,12
,13
]}

Dorfman, David M. ^{[11
,14
]}

Hideshima, Teru ^{[2
,11
]}

Anderson, Kenneth C. ^{[1
,2
,11
,15
]}

机构：

[1] Harvard Med Sch, LeBow Inst Myeloma Therapeut, Boston, MA 02115 USA

[2] Harvard Med Sch, Jerome Lipper Multiple Myeloma Ctr, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA

[3] Ilia State Univ, Inst Med & Publ Hlth Res, Tbilisi, Georgia

[4] Tokai Univ, Dept Hematol Oncol, Sch Med, Isehara, Kanagawa, Japan

[5] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Internal Med 1, Div Haematol, Thessaloniki, Greece

[6] Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada

[7] Univ Hosp Ostrava, Dept Hematooncol, Ostrava, Czech Republic

[8] Masaryk Univ, Ostrava, Czech Republic

[9] Univ Ostrava, Dept Internal Studies, Ostrava, Czech Republic

[10] Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, LeBow Inst Myeloma Therapeut, Boston, MA 02115 USA

[11] Harvard Med Sch, Boston, MA 02115 USA

[12] Dana Farber Canc Inst, LeBow Inst Myeloma Therapeut, Boston, MA 02115 USA

[13] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA

[14] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA

[15] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

关键词：

D O I：

10.1182/blood-2022-169943

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2081 / 2082

页数：2